Looking to publish in Cns Drugs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowCNS Drugs provides researchers and healthcare professionals with information on drug therapies for the management of neurological and psychiatric disorders. The journal publishes reviews and original research articles addressing pharmacology, efficacy, adverse effects, newly developed drugs and drug classes, therapeutic implications of research into disease aetiology, and practical management of specific clinical situations.
Looking to publish in Cns Drugs? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Cns Drugs accepts the following article types. Click on an article type to view submission instructions.
Review Article
Systematic Review
Original Research
Narrative Reviews
Therapy In Practice
Letter To The Editor
Research Letter
Recent Publications
Clinical Predictors of Antidepressant Effects of Ketamine and Esketamine in Treatment-Resistant Unipolar and Bipolar Depression: A Systematic Review
Omer A. Syed, Valentyn Sobolenko, Sean M. Nestor, Muhammad Ishrat Husain, Nir Lipsman, Fahad Alam, Peter Giacobbe
Enhancing Drug Response Prediction in Epilepsy with Emerging Multimodal Models: Focus on Clinical, Pharmacologic, and Genomic Factors
Alison Anderson, Richard Shek-kwan Chang, Mark Howard, Zhibin Chen, Duong Nhu, Zongyuan Ge, Patrick Kwan
Correction: Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes
Enhui Wang, Yilin Liu, Yucheng Wang, Xinyu Han, Yifang Zhou, Lingli Zhang, Yanqing Tang
Comment on “Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta-analysis of Congenital Malformations and Prenatal Outcomes”
Per Damkier
Authors’ Reply to Damkier: Comment on “Comparative Safety of Antipsychotic Medications and Mood Stabilizers During Pregnancy: A Systematic Review and Network Meta Analysis of Congenital Malformations and Prenatal Outcomes”
Enhui Wang, Yilin Liu, Yucheng Wang, Xinyu Han, Yifang Zhou, Lingli Zhang, Yanqing Tang
Frequently asked questions
How long does it take to publish?
Articles are published online after receipt of the corrected proofs.
Reformat to Cns Drugs using Livewrite PremiumIs a cover letter required?
A covering letter should be included with submission and should state the article type, why the paper is important, what is covered in the review or found in the study, why it would interest the journal readership, and any other pertinent information. If the manuscript was previously reviewed by another journal, prior editorial or referee comments and the response to them should also be provided.
Reformat to Cns Drugs using Livewrite PremiumWhat are the publication costs?
Open access APC: £3290.00 GBP / $5290.00 USD / €4190.00 EUR, subject to VAT or local taxes where applicable. Subscription publishing has no APC.
Reformat to Cns Drugs using Livewrite Premium